COSCIENS Biopharma Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -38.1% | -38.1% | -10.4% |
| FY2022 | 14.5% | 14.5% | 12.4% |
| FY2023 | -16.6% | -16.6% | -14.7% |
| FY2024 | -116.3% | -116.3% | -43.7% |
| FY2025 | -269.6% | -269.6% | -48.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -38.1% | -38.1% | -10.4% |
| FY2022 | 14.5% | 14.5% | 12.4% |
| FY2023 | -16.6% | -16.6% | -14.7% |
| FY2024 | -116.3% | -116.3% | -43.7% |
| FY2025 | -269.6% | -269.6% | -48.3% |